Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

OCUL holding history

Ocular Therapeutix, Inc in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

OCUL overviewAll 13F holders of OCULFull Q2 2026 holdings

Shares (Q2 2026)
124,457
Value
$1.22M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of OCUL by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026124,457$1.22M<0.1%−94,021−43.0%ReducedHolders
Q1 2026218,478$1.85M<0.1%−935,432−81.1%ReducedHolders
Q4 20251,153,910$14.0M<0.1%+1,040,631+918.6%AddedHolders
Q3 2025113,279$1.32M<0.1%+10,446+10.2%AddedHolders
Q2 2025102,833$954.3K<0.1%+42,710+71.0%AddedHolders
Q1 202560,123$440.7K<0.1%+28,704+91.4%AddedHolders
Q4 202431,419$268.3K<0.1%+31,419NewHolders
Q2 20240$00.0%−160,142−100.0%Sold outHolders
Q1 2024160,142$1.46M<0.1%−230,693−59.0%ReducedHolders
Q4 2023390,835$1.74M<0.1%−194,045−33.2%ReducedHolders
Q3 2023584,880$1.84M<0.1%−71,225−10.9%ReducedHolders
Q2 2023656,105$3.39M<0.1%−443,665−40.3%ReducedHolders
Q1 20231,099,770$5.80M<0.1%+131,436+13.6%AddedHolders
Q4 2022968,334$2.72M<0.1%+176,045+22.2%AddedHolders
Q3 2022792,289$3.29M<0.1%+43,824+5.9%AddedHolders
Q2 2022748,465$3.01M<0.1%+134,927+22.0%AddedHolders
Q1 2022613,538$3.04M<0.1%+133,870+27.9%AddedHolders
Q4 2021479,668$3.34M<0.1%−87,434−15.4%ReducedHolders
Q3 2021567,102$5.67M<0.1%−120,078−17.5%ReducedHolders
Q2 2021687,180$9.74M<0.1%+35,052+5.4%AddedHolders
Q1 2021652,128$10.7M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.